Introduction
============

Myopia is a refractive visual disorder that is considered an important public health problem, especially in Asian populations. High myopia is generally defined by a spherical equivalent (SE) refractive error \<−6 diopters (D) or an axial length (AL) \>26 mm that can cause blindness associated with an increased risk of various ocular diseases, including retinal detachment, glaucoma, cataracts, and macular degeneration.[@b1-opth-9-2005] Because of its high prevalence compared to the global average in Asian countries such as the People's Republic of China, Singapore, and Japan, high myopia imposes enormous economic and social burdens in these regions.[@b2-opth-9-2005]--[@b5-opth-9-2005]

Although the cause of myopia is unclear, family-based studies and twin studies have shown that genetic factors contribute to its development and progression.[@b6-opth-9-2005]--[@b13-opth-9-2005] Therefore, the identification of genetic factors is important for establishing preventive strategies for myopia. To date, 18 genetic loci for myopia (MYP1 to MYP18) have been reported by familial linkage studies.[@b14-opth-9-2005] In the past several years, genome-wide association studies have led to the identification of many important genetic loci/genes involved in myopia, refractive error, and elongation of AL.[@b15-opth-9-2005]--[@b18-opth-9-2005] Recently, environmental factors such as education have been reported to influence the association between genetic factors and myopia.[@b19-opth-9-2005]--[@b21-opth-9-2005]

The paired box 6 (*PAX6*) gene, located on chromosome 11p13, is a highly conserved family of transcription factors containing the paired and homeobox DNA-binding domains. PAX6 regulates the expression of various molecules, such as cell adhesion molecules, cell--cell signaling molecules, hormones, and structural eye proteins, and the gene plays a critical role in the development of the central nervous system and the eye.[@b22-opth-9-2005] Mutations in the *PAX6* gene result in various ocular diseases including aniridia, foveal hypoplasia, presenile cataract, and aniridia-related keratopathy.[@b23-opth-9-2005] In 2004, a genome-wide linkage analysis in UK dizygotic twins showed the highest peak at the 11p13 locus and strong linkage for refractive error in the vicinity of *PAX6* at this locus.[@b24-opth-9-2005] Subsequently, the results of some genetic surveys suggested an association of single nucleotide polymorphisms (SNPs) in *PAX6* with high and/or extreme myopia in Taiwanese, Chinese, and Japanese populations,[@b25-opth-9-2005]--[@b28-opth-9-2005] suggesting that *PAX6* may contribute to the development of high/extreme myopia through genetic polymorphisms. However, other studies have reported a lack of association of *PAX6* SNPs with refractive error, myopia, or high myopia in British, Chinese, and mixed populations of some ethnic groups (including mainly Caucasians).[@b29-opth-9-2005]--[@b32-opth-9-2005]

Further genetic studies thus are needed to clarify the contribution of the *PAX6* region to myopia development. The aim of the current study was to investigate whether SNPs in the *PAX6* region are associated with high/extreme myopia in our Japanese population.

Methods
=======

Subjects
--------

We recruited 1,585 unrelated Japanese patients with high myopia (SE\<−9.00 D in at least one eye) and 1,011 unrelated healthy Japanese controls (SE≥−1.00 D in both eyes) at Yokohama City University, Okada Eye Clinic, and Aoto Eye Clinic in Japan. Participants were unrelated to each other, had similar social backgrounds, and resided in the same urban area. All participants were diagnosed by comprehensive ophthalmologic tests, including AL, fundus examination, spherical power, and corneal curvature (autorefractor; NIDEK \[Gamagori, Japan\]; ARK-730A, ARK-700A, TOPCON \[Tokyo, Japan\]; KP-8100P, Biometer/Pachymeter AL-2000; Tomey Corporation, Nagoya, Japan). Those with high myopia had no known genetic diseases associated with myopia and/or high myopia, including glaucoma, keratoconus, and Marfan syndrome. We excluded individuals younger than 20 years, which may include potential myopia patients, from the control cohort. Informed consent was obtained from all participants. The study methodology adhered to the tenets of the Declaration of Helsinki and was approved by the relevant ethics committees in Yokohama City University, Okada Eye Clinic, and Aoto Eye Clinic.

DNA and *PAX6* genotyping
-------------------------

The QIAamp DNA Blood Maxi Kit (Qiagen, Hilden, Germany) was used to collect peripheral blood lymphocytes and extract genomic DNA from peripheral blood cells. Procedures were performed under standardized conditions to prevent variation in DNA quality.

We evaluated five SNPs in the *PAX6* gene regions: rs662702, rs3026393, rs644242, rs3026390, and rs667773. All five have previously been reported to be associated with high or extreme myopia.[@b25-opth-9-2005]--[@b28-opth-9-2005] Genotyping of all SNPs was performed using the TaqMan 5′ exonuclease assay with primer--probe sets supplied by Applied Biosystems (Foster City, CA, USA). Polymerase chain reaction (PCR) was performed using a reaction mixture with a total volume of 10 μL containing 1× TaqMan Universal PCR Master Mix (Applied Biosystems), 24 nM of each primer--probe set, and 3 ng genomic DNA. The PCR conditions were as follows: 95°C for 10 minutes, followed by 40 cycles of denaturation at 92°C for 15 seconds and annealing/extension at 60°C for 1 minute. The probe fluorescence signal was detected using the StepOnePlus Real-Time PCR System (Applied Biosystems) following the manufacturer's instructions.

Statistical analysis
--------------------

Genetic data were analyzed using SNP and Variation Suite v8 (Golden Helix, Inc., Bozeman, MT, USA, <http://www.goldenhelix.com>). Multiple inheritance models were applied in analysis of genotype data to assess each risk allele; additive (R/R vs R/nR vs nR/nR), dominant (R/R + R/nR vs nR/nR), and recessive (R/R vs R/nR + nR/nR) models (assuming that R is the risk allele and nR is the non-risk allele) were assessed. All *P*-values and odds ratios (ORs) were adjusted for age and sex. Linkage disequilibrium (LD) was assessed using Haploview 4.1 (Broad Institute, Cambridge, MA, USA).[@b33-opth-9-2005]

Results
=======

The clinical characteristics of the study populations are shown in [Table 1](#t1-opth-9-2005){ref-type="table"}. Patient age ranged from 12 to 78 years (mean 38.8±12.2 years), and 44.2% of patients were male. The average SEs were −10.94±2.06 D (range −4.50 to −22.75 D) in the right eye and −10.82±2.07 D (range −4.50 to −24.50 D) in the left eye. The average AL was 27.55±1.22 mm (range 23.92--33.85 mm) for the right eye and 27.51±1.24 mm (range 23.99--34.74 mm) for the left eye. For the controls, the age ranged from 20 to 87 years (mean 58.2±12.3 years), and 41.6% of them were male. The average SEs were 0.48±0.64 D (range −1.00 to 3.50 D) in the right eye and 0.48±0.63 D (range −1.00 to 3.00 D) in the left eye. Average AL values were 23.22±0.80 mm (range 18.76--25.96 mm) and 23.20±0.79 mm (range 18.99--26.05 mm) for the right and left eyes, respectively.

The genotype frequencies of all five SNPs in *PAX6* were in Hardy--Weinberg equilibrium in controls (*P*\>0.05). The magnitude of LD among three SNPs (rs662702, rs644242, and rs667773) was extremely high (*r*^2^≥0.98) while the remaining two SNPs (rs3026393 and rs3026390) were in complete LD (*r*^2^=1.00). These two LD blocks were not linked to each other (*r*^2^≤0.10).

[Table 2](#t2-opth-9-2005){ref-type="table"} shows genotypic association results for the SNPs after stratification according to SE in high myopia cases; that is, \<−9.0 D in at least one eye, \<−9.0 D in both eyes, \<−11.0 D in both eyes, \<−13.0 D in both eyes, and \<−15.0 D in both eyes. For rs662702, rs644242, and rs667773, ORs for their risk alleles tended to increase according to the progression of SE in the additive and recessive models, and marginal associations were found in patients with SE\<−15.0 D in both eyes for rs644242 and rs667773 (rs644242: *P*=0.069 and OR=2.51; rs667773: *P*=0.071 and OR=2.50 for the additive model; rs644242: *P*=0.093 and OR=2.56; rs667773: *P*=0.095 and OR=2.55 for the recessive model). On the other hand, for rs3026393 and rs3026390, ORs for their risk alleles tended to increase with the progression of SE in the dominant model, and marginal associations were found in patients with SE\<−15.0 D in both eyes (rs3026393: *P*=0.068 and OR=2.32; rs3026390: *P*=0.075 and OR=2.28).

[Table 3](#t3-opth-9-2005){ref-type="table"} shows genotypic association results after stratification according to AL in high myopia cases, as follows: \>26, \>28, \>29, and \>30 mm in both eyes. For rs662702, rs644242, and rs667773, ORs for their risk alleles tended to increase according to the progression of AL in the additive and recessive models, and the highest ORs were observed in patients with AL\>30 mm in both eyes in the recessive model (OR=1.87--1.90). On the other hand, for rs3026393 and rs3026390, ORs for their risk alleles tended to increase according to the progression of AL in the dominant model, and the highest ORs were observed in patients with AL\>30 mm in both eyes (OR=1.79 and 1.78, respectively). However, no significant associations were found in this genotypic analysis.

Discussion
==========

The aim of the present study was to assess whether polymorphisms in the *PAX6* gene region affect the development of high/extreme myopia in our Japanese population. Patients with SE\<−9.00 D in at least one eye were selected for this study because higher degree of myopia suggests that genetic factors may show stronger involvement. We genotyped five polymorphisms in the region and found that the relationship between *PAX6* SNPs and myopia became stronger with the progression of myopia, although it did not reach statistical significance. Our findings suggest that *PAX6* SNPs play an important role in the risk of extreme myopia in the Japanese population.

Tsai et al[@b25-opth-9-2005] found a significantly higher frequency of the CC genotype of rs667773 in extreme myopia (SE\<−10.0 D in both eyes) (OR=5.265) but not high myopia (SE\<−6.0 D in both eyes) compared to controls in Chinese Taiwanese. Liang et al[@b27-opth-9-2005] reported that the frequencies of the GG genotype of rs662702 and rs644242, which are in extremely high LD with rs667773, significantly increased with the progression of myopia in Chinese Taiwanese and that the GG genotypes of rs662702 and rs644242 had the highest ORs (2.1 and 2.3, respectively) in extreme myopia (SE≤−11.0 D in both eyes). Additionally, Miyake et al[@b28-opth-9-2005] reported that rs644242 showed a significant association with high (AL≥26 mm in both eyes) and extreme (AL≥28 mm in both eyes) myopia in a Japanese population and that the G allele was protective for both. In the present study, in a Japanese population, we found that the CC genotype of rs667773 and the GG genotype of rs644242 (recessive model) had the highest ORs (2.55 and 2.56, respectively) in extreme myopia with SE\<−15.0 D in both eyes and that the GG genotype of rs662702 (recessive model) had the highest OR (1.90) in extreme myopia with AL≥30 mm in both eyes. These findings are in line with the previous studies. Considering the above, the risk allele(s) of rs667773, rs644242, and/or rs662702 may contribute to the development of extreme myopia under the recessive model.

On the other hand, other studies have not found a relationship between rs667773/rs662702 and myopia in several populations.[@b26-opth-9-2005],[@b29-opth-9-2005]--[@b32-opth-9-2005] However, these authors, with the exception of Dai et al,[@b32-opth-9-2005] did not perform an analysis targeting extreme myopia, and moreover, almost all of them, including Dai et al,[@b32-opth-9-2005] used limited sample sizes, with the potential to yield false results.[@b26-opth-9-2005],[@b29-opth-9-2005]--[@b32-opth-9-2005] Therefore, it is assumed that these previous studies had not been performed under appropriate conditions to assess associations between rs667773/rs644242/rs662702 and extreme myopia.

Han et al[@b26-opth-9-2005] demonstrated that the T allele of rs3026393 and the A allele of rs3026390 are associated with a significantly increased risk of high myopia (\<−6.0 D) in dominant and recessive models in Han Chinese. In the present study, we found that the ORs of the G allele of rs3026393 and the G allele of rs3026390 increased according to the progression of myopia in the dominant model. Our result diverges from that of Han et al,[@b26-opth-9-2005] in that the disease risk-related allele differs between the present and previous studies for rs3026393 and rs3026390. Moreover, other studies found no relationship between the genotypes and myopia in Han Chinese, Chinese Taiwanese, and British populations.[@b27-opth-9-2005],[@b29-opth-9-2005],[@b31-opth-9-2005],[@b32-opth-9-2005] None of these previous studies[@b26-opth-9-2005],[@b27-opth-9-2005],[@b29-opth-9-2005],[@b31-opth-9-2005],[@b32-opth-9-2005] involved analyses targeting extreme myopia with SE\<−13.0 D or \<−15.0 D, which had higher ORs (OR\>1.50) at rs3026393 and rs3026390 in the present study (the study by Han et al[@b26-opth-9-2005] used the lowest SE cutoff point \[≤−10.0 D\] among the previous studies). Because the present study found that ORs for rs3026393 and rs3026390 were proportionate to the progression of myopia in the dominant model and that lower ORs (≤1.23) were observed in myopia patients with SE\<−11.0 D, there is a possibility that these earlier studies[@b26-opth-9-2005],[@b27-opth-9-2005],[@b29-opth-9-2005],[@b31-opth-9-2005],[@b32-opth-9-2005] failed to detect the association between rs3026393/rs3026390 and extreme myopia.

In conclusion, we found that all of the *PAX6* SNPs tested in this study were associated with an increased risk of extreme myopia. However, the results did not reach statistical significance; this is probably due to small sample sizes after stratification by SE or AL. Further genetic studies with larger sample sizes and consideration of degree of myopia are needed to elucidate the possible contributions of the *PAX6* region in myopia development.
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###### 

Clinical characteristics of the study populations

  Parameters                                                        High myopia[b](#tfn2-opth-9-2005){ref-type="table-fn"} (n=1,585)   Controls[c](#tfn3-opth-9-2005){ref-type="table-fn"} (n=1,011)
  ----------------------------------------------------------------- ------------------------------------------------------------------ ---------------------------------------------------------------
  Male, %                                                           44.2                                                               41.6
  Mean age,[a](#tfn1-opth-9-2005){ref-type="table-fn"} (years)      38.8±12.2                                                          58.2±12.3
  Age range                                                         (12, 78)                                                           (20, 87)
  Mean SE,[a](#tfn1-opth-9-2005){ref-type="table-fn"} diopter (D)                                                                      
   Right eyes                                                       −10.94±2.06                                                        0.48±0.64
   Left eyes                                                        −10.82±2.07                                                        0.48±0.63
  Range of SE                                                                                                                          
   Right eyes                                                       (−4.50, −22.75)                                                    (−1.00, 3.50)
   Left eyes                                                        (−4.50, −24.50)                                                    (−1.00, 3.00)
  Mean AL,[a](#tfn1-opth-9-2005){ref-type="table-fn"} mm                                                                               
   Right eyes                                                       27.55±1.22                                                         23.22±0.80
   Left eyes                                                        27.51±1.24                                                         23.20±0.79
  Range of AL                                                                                                                          
   Right eyes                                                       (23.92, 33.85)                                                     (18.76, 25.96)
   Left eyes                                                        (23.99, 34.74)                                                     (18.99, 26.05)

**Notes:**

Data presented are mean ± standard deviation.

High myopia cases defined as SE\<−9.0 D in at least one eye.

Controls defined as SE≥−1.0 D in both eyes.

**Abbreviations:** AL, axial length; SE, spherical equivalent.

###### 

Genotypic association results for five *PAX6* SNPs after stratification according to spherical equivalent refractive error

  SNP         Position on Chr 11 (build 37.1)   Alleles (1\>2)   Risk allele   Phenotype   n       Genotype (\[R/R\]/\[R/nR\]/\[nR/nR\]) frequency, %   Genetic models[a](#tfn5-opth-9-2005){ref-type="table-fn"}                                                                                    
  ----------- --------------------------------- ---------------- ------------- ----------- ------- ---------------------------------------------------- ----------------------------------------------------------- ---------------- ------- ------------------- ------- ------------------- ------- -------------------
  rs662702    31,809,070                        G\>A             G             Controls    ≥−1     Both                                                 1,011                                                       79.4/19.1/1.5                                                                    
                                                                               Cases       \<−9    At least one                                         1,585                                                       80.8/17.6/1.5    0.480   1.09 (0.86--1.37)   0.379   1.46 (0.63--3.39)   0.603   1.07 (0.83--1.38)
                                                                                           \<−9    Both                                                 1,252                                                       80.8/17.4/1.8    0.643   1.06 (0.83--1.36)   0.486   1.36 (0.58--3.21)   0.764   1.04 (0.79--1.38)
                                                                                           \<−11   Both                                                 394                                                         82.3/14.9/2.8    0.663   1.07 (0.78--1.47)   0.662   0.81 (0.31--2.12)   0.497   1.14 (0.78--1.65)
                                                                                           \<−13   Both                                                 130                                                         85.3/12.4/2.3    0.399   1.22 (0.76--1.94)   0.948   1.05 (0.27--4.06)   0.329   1.31 (0.75--2.29)
                                                                                           \<−15   Both                                                 36                                                          88.9/11.1/0.0    0.171   1.89 (0.69--5.17)   nd      nd                  0.236   1.85 (0.62--5.48)
  rs3026393   31,812,215                        T\>G             G             Controls    ≥−1     Both                                                 1,011                                                       22.7/48.6/28.8                                                                   
                                                                               Cases       \<−9    At least one                                         1,585                                                       22.7/50.0/27.3   0.791   0.98 (0.85--1.13)   0.950   1.01 (0.80--1.26)   0.607   0.94 (0.74--1.19)
                                                                                           \<−9    Both                                                 1,252                                                       22.4/50.3/27.2   0.851   0.99 (0.85--1.15)   0.876   1.02 (0.80--1.30)   0.629   0.94 (0.72--1.22)
                                                                                           \<−11   Both                                                 394                                                         22.8/52.9/24.3   0.844   1.02 (0.83--1.25)   0.214   1.23 (0.89--1.71)   0.335   0.85 (0.60--1.19)
                                                                                           \<−13   Both                                                 130                                                         24.0/55.8/20.2   0.437   1.12 (0.84--1.48)   0.078   1.54 (0.94--2.52)   0.632   0.89 (0.55--1.43)
                                                                                           \<−15   Both                                                 36                                                          25.0/61.1/13.9   0.384   1.24 (0.76--2.02)   0.068   2.32 (0.87--6.20)   0.769   0.89 (0.39--2.00)
  rs644242    31,812,801                        G\>T             G             Controls    ≥−1     Both                                                 1,011                                                       79.5/19.1/1.4                                                                    
                                                                               Cases       \<−9    At least one                                         1,585                                                       81.1/17.5/1.5    0.493   1.08 (0.86--1.37)   0.366   1.49 (0.63--3.51)   0.623   1.07 (0.82--1.38)
                                                                                           \<−9    Both                                                 1,252                                                       81.1/17.2/1.7    0.641   1.06 (0.83--1.36)   0.460   1.39 (0.58--3.35)   0.771   1.04 (0.79--1.38)
                                                                                           \<−11   Both                                                 394                                                         82.9/14.5/2.6    0.519   1.11 (0.81--1.53)   0.773   0.86 (0.32--2.35)   0.389   1.18 (0.81--1.72)
                                                                                           \<−13   Both                                                 130                                                         86.0/11.6/2.3    0.315   1.27 (0.79--2.04)   0.960   1.04 (0.27--4.04)   0.240   1.39 (0.79--2.45)
                                                                                           \<−15   Both                                                 36                                                          91.7/8.3/0.0     0.069   2.51 (0.79--7.98)   nd      nd                  0.093   2.56 (0.75--8.72)
  rs3026390   31,813,509                        A\>G             G             Controls    ≥−1     Both                                                 1,011                                                       22.5/48.8/28.7                                                                   
                                                                               Cases       \<−9    At least one                                         1,585                                                       22.8/50.0/27.2   0.758   0.98 (0.85--1.13)   0.992   1.00 (0.80--1.26)   0.596   0.94 (0.74--1.19)
                                                                                           \<−9    Both                                                 1,252                                                       22.5/50.4/27.1   0.819   0.98 (0.84--1.15)   0.907   1.01 (0.80--1.29)   0.611   0.93 (0.72--1.21)
                                                                                           \<−11   Both                                                 394                                                         22.7/53.3/24.0   0.860   1.02 (0.83--1.25)   0.207   1.23 (0.89--1.72)   0.310   0.84 (0.60--1.18)
                                                                                           \<−13   Both                                                 130                                                         23.8/56.2/20.0   0.468   1.11 (0.84--1.47)   0.084   1.53 (0.93--2.50)   0.598   0.88 (0.55--1.42)
                                                                                           \<−15   Both                                                 36                                                          25.0/61.1/13.9   0.399   1.23 (0.76--2.01)   0.075   2.28 (0.85--6.09)   0.764   0.88 (0.39--1.99)
  rs667773    31,815,362                        C\>T             C             Controls    ≥−1     Both                                                 1,011                                                       79.6/18.9/1.5                                                                    
                                                                               Cases       \<−9    At least one                                         1,585                                                       81.1/17.4/1.5    0.502   1.08 (0.86--1.37)   0.344   1.51 (0.65--3.54)   0.644   1.06 (0.82--1.38)
                                                                                           \<−9    Both                                                 1,252                                                       81.1/17.2/1.7    0.637   1.06 (0.83--1.36)   0.438   1.41 (0.59--3.37)   0.775   1.04 (0.79--1.37)
                                                                                           \<−11   Both                                                 394                                                         83.0/14.4/2.6    0.540   1.10 (0.80--1.52)   0.797   0.88 (0.32--2.38)   0.416   1.17 (0.80--1.70)
                                                                                           \<−13   Both                                                 130                                                         86.6/11.0/2.4    0.264   1.31 (0.81--2.12)   0.969   1.03 (0.27--3.97)   0.187   1.46 (0.82--2.60)
                                                                                           \<−15   Both                                                 36                                                          91.7/8.3/0.0     0.071   2.50 (0.79--7.93)   nd      nd                  0.095   2.55 (0.75--8.67)

**Notes:**

Multiple inheritance models were applied in analysis of genotype data to assess each risk allele: additive (R/R vs R/nR vs nR/nR), dominant (R/R + R/nR vs nR/nR), and recessive (R/R vs R/nR + nR/nR) models were assessed. *P*-values and ORs were adjusted for age and sex.

**Abbreviations:** 1, major allele; 2, minor allele; Chr, chromosome; CI, confidence interval; D, diopter; nd, not detected; nR, non-risk allele; OR, odds ratio; *PAX6*, paired box 6; R, risk allele; SE, spherical equivalent; SNPs, single nucleotide polymorphisms.

###### 

Genotypic association results for five *PAX6* SNPs after stratification by axial length

  SNP         Position on Chr 11 (build 37.1)   Alleles (1\>2)   Risk allele   Phenotype   n      Genotype (\[R/R\]/\[R/nR\]/\[nR/nR\]) frequency, %   Genetic models[a](#tfn7-opth-9-2005){ref-type="table-fn"}                                                                                     
  ----------- --------------------------------- ---------------- ------------- ----------- ------ ---------------------------------------------------- ----------------------------------------------------------- ---------------- ------- ------------------- ------- -------------------- ------- -------------------
  rs662702    31,809,070                        G\>A             G             Controls    \<24   Both                                                 779                                                         78.7/19.5/1.8                                                                     
                                                                               Cases       \>26   Both                                                 1,247                                                       81.1/17.3/1.5    0.436   1.11 (0.85--1.47)   0.159   2.00 (0.77--5.20)    0.665   1.07 (0.79--1.45)
                                                                                           \>28   Both                                                 361                                                         83.4/14.6/2.0    0.149   1.32 (0.90--1.92)   0.168   2.36 (0.68--8.15)    0.237   1.30 (0.84--2.01)
                                                                                           \>29   Both                                                 111                                                         86.4/11.8/1.8    0.115   1.56 (0.88--2.78)   0.475   1.79 (0.34--9.43)    0.106   1.75 (0.87--3.51)
                                                                                           \>30   Both                                                 30                                                          86.7/10.0/3.3    0.350   1.52 (0.60--3.85)   0.930   1.10 (0.12--10.05)   0.258   1.90 (0.59--6.11)
  rs3026393   31,812,215                        T\>G             G             Controls    \<24   Both                                                 799                                                         22.0/49.7/28.3                                                                    
                                                                               Cases       \>26   Both                                                 1,247                                                       22.7/50.7/26.5   0.630   1.04 (0.88--1.24)   0.744   1.05 (0.80--1.37)    0.642   1.07 (0.80--1.43)
                                                                                           \>28   Both                                                 361                                                         23.4/52.4/24.2   0.347   1.12 (0.88--1.42)   0.160   1.31 (0.90--1.92)    0.917   1.02 (0.69--1.51)
                                                                                           \>29   Both                                                 111                                                         25.5/53.6/20.9   0.272   1.21 (0.86--1.71)   0.116   1.58 (0.88--2.81)    0.831   1.06 (0.60--1.88)
                                                                                           \>30   Both                                                 30                                                          30.0/53.3/16.7   0.474   1.23 (0.70--2.14)   0.248   1.79 (0.64--5.01)    0.953   1.03 (0.41--2.55)
  rs644242    31,812,801                        G\>T             G             Controls    \<24   Both                                                 799                                                         78.8/19.5/1.7                                                                     
                                                                               Cases       \>26   Both                                                 1,247                                                       81.3/17.2/1.5    0.475   1.11 (0.84--1.45)   0.156   2.05 (0.77--5.42)    0.717   1.06 (0.78--1.44)
                                                                                           \>28   Both                                                 361                                                         84.0/14.0/2.0    0.119   1.35 (0.93--2.00)   0.167   2.40 (0.68--8.39)    0.189   1.34 (0.86--2.10)
                                                                                           \>29   Both                                                 111                                                         86.4/11.8/1.8    0.123   1.56 (0.87--2.78)   0.486   1.77 (0.33--9.35)    0.113   1.72 (0.86--3.46)
                                                                                           \>30   Both                                                 30                                                          86.7/10.0/3.3    0.363   1.52 (0.59--3.85)   0.939   1.09 (0.12--9.98)    0.269   1.87 (0.58--6.04)
  rs3026390   31,813,509                        A\>G             G             Controls    \<24   Both                                                 799                                                         21.8/49.8/28.4                                                                    
                                                                               Cases       \>26   Both                                                 1,247                                                       22.8/50.8/26.4   0.619   1.04 (0.88--1.24)   0.728   1.05 (0.80--1.38)    0.641   1.07 (0.80--1.43)
                                                                                           \>28   Both                                                 361                                                         23.3/52.8/23.9   0.326   1.13 (0.89--1.43)   0.135   1.34 (0.91--1.96)    0.937   1.02 (0.69--1.50)
                                                                                           \>29   Both                                                 111                                                         25.2/54.1/20.7   0.273   1.21 (0.86--1.71)   0.108   1.59 (0.89--2.84)    0.863   1.05 (0.59--1.86)
                                                                                           \>30   Both                                                 30                                                          30.0/53.3/16.7   0.477   1.22 (0.70--2.14)   0.251   1.78 (0.63--5.00)    0.953   1.03 (0.41--2.55)
  rs667773    31,815,362                        C\>T             C             Controls    \<24   Both                                                 799                                                         78.8/19.4/1.8                                                                     
                                                                               Cases       \>26   Both                                                 1,247                                                       81.4/17.1/1.5    0.417   1.12 (0.85--1.47)   0.146   2.06 (0.79--5.41)    0.647   1.07 (0.79--1.46)
                                                                                           \>28   Both                                                 361                                                         84.6/13.5/2.0    0.083   1.39 (0.95--2.04)   0.164   2.38 (0.69--8.22)    0.130   1.41 (0.90--2.19)
                                                                                           \>29   Both                                                 111                                                         86.4/11.8/1.8    0.111   1.56 (0.88--2.78)   0.473   1.79 (0.34--9.42)    0.102   1.75 (0.87--3.51)
                                                                                           \>30   Both                                                 30                                                          86.7/10.0/3.3    0.349   1.52 (0.60--3.85)   0.930   1.10 (0.12--10.05)   0.258   1.90 (0.59--6.12)

**Notes:**

Multiple inheritance models were applied in analysis of genotype data to assess each risk allele: additive (R/R vs R/nR vs nR/nR), dominant (R/R + R/nR vs nR/nR), and recessive (R/R vs R/nR + nR/nR) models were assessed. *P*-values and ORs were adjusted for age and sex.

**Abbreviations:** 1, major allele; 2, minor allele; AL, axial length; CI, confidence interval; nR, non-risk allele; OR, odds ratio; *PAX6*, paired box 6; R, risk allele; SNPs, single nucleotide polymorphisms.
